Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Today's highlights: 25 August 2010

This article was originally published in Scrip

Executive Summary

FDA hands refusal to file letter to EpiCept for lead leukaemia product
Strike date set in AstraZeneca UK pension dispute
Extended review for Acetadote supplement hits Cumberland shares
Pipeline progress at Oxford BioMedica as H1 losses reach £2.9 million
Baxter acquires alpha 1-antitrypsin therapy and technology from Kamada
Pfizer gets WHO approval for pneumocococal vaccine
Indian govt paper to reignite debate on compulsory licensing
First Phase III results for perampanel in epilepsy look positive

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC009972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel